Follicle-Stimulating Hormone (FSH) and the Onset of Puberty

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

November 30, 2010

Study Completion Date

December 31, 2010

Conditions
Delayed PubertyPrecocious Puberty
Interventions
DRUG

Leuprolide Acetate - Early Puberty Leuprolide Visit

Dose of 10 mcg/kg Sub cutaneous once at 0800 on day 2 of the Early Puberty Luprolide Visit

DRUG

Ganirelix - Early Puberty Ganirelix Visit

Dose of 2.5 mcg/kg Sub-cutaneous once at 17:30 on day 1 of the Early Puberty Ganirelix Visit and once at 08:00 on day 2 of the Early Puberty Ganirelix Visit

DRUG

Ganirelix - Delayed Puberty Ganirelix Visit

Ganirelix is administered at a dose of 2.5 mcg/kg sub cutaneous at 17:30 on day 1 and once at 08:00 on day 2 of the Ganirelix Delayed Puberty Visit

DRUG

Leuprolide Acetate- Delayed Puberty Leuprolide Visit

Leuprolide acetate is given at a dose of10 mcg/kg at 0800 on day 2 of the Delayed Puberty Leuprolide Visit

Trial Locations (1)

84108

Utah Diabetes Center, Salt Lake City

All Listed Sponsors
collaborator

University of Michigan

OTHER

collaborator

University of Chicago

OTHER

lead

University of Utah

OTHER

NCT00734279 - Follicle-Stimulating Hormone (FSH) and the Onset of Puberty | Biotech Hunter | Biotech Hunter